"Isala is een groot regioziekenhuis. Woont u in de regio, dan is Isala – met vijf locaties in Zwolle, Meppel, Steenwijk, Kampen en Heerde – uw ziekenhuis bij gezondheidsproblemen. Voor complexe zorg komen ook mensen uit omliggende ziekenhuizen en ver daarbuiten naar Isala. In Isala zorgen we niet alleen voor u, maar doen we dat samen met u. Samen komen we tot de juiste behandeling."

During the past decade, Isala Klinieken conducted 195 clinical trials. In the 10-year time frame, 195 clinical trials started and 52 clinical trials were completed, i.e. on average, 26.7% percent of trials that started reached the finish line to date. In the past 5 years, 79 clinical trials started and 36 clinical trials were completed. i.e. 45.6% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Isala Klinieken" #1 sponsor was "Radboud University Medical Center" with 17 trials, followed by "Isala" with 13 trials sponsored, "The Netherlands Cancer Institute" with 12 trials sponsored, "Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)" with 11 trials sponsored and "University Medical Center Groningen" with 11 trials sponsored. Other sponsors include 250 different institutions and companies that sponsored additional 138 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Isala Klinieken" #1 collaborator was "ZonMw: The Netherlands Organisation for Health Research and Development" with 20 trials as a collaborator, "Dutch Cancer Society" with 14 trials as a collaborator, "Isala" with 13 trials as a collaborator, "Borstkanker Onderzoek Groep" with 10 trials as a collaborator and "Erasmus Medical Center" with 9 trials as a collaborator. Other collaborators include 401 different institutions and companies that were collaborators in the rest 280 trials.

According to Clinical.Site data, the most researched conditions in "Isala Klinieken" are "Heart Failure" (15 trials), "Atrial Fibrillation" (14 trials), "Breast Cancer" (11 trials), "Lung Cancer" (11 trials) and "Coronary Artery Disease" (8 trials). Many other conditions were trialed in "Isala Klinieken" in a lesser frequency.

Most popular intervention types in "Isala Klinieken" are "Drug" (151 trials), "Device" (61 trials), "Procedure" (53 trials), "Other" (42 trials) and "Radiation" (15 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (39 trials), "Atezolizumab" (6 trials), "cisplatin" (6 trials), "radiation therapy" (5 trials) and "Docetaxel" (4 trials). Other intervention names were less common.

The vast majority of trials in "Isala Klinieken" are 279 trials for "All" genders, 31 trials for "Female" genders and 8 trials for "Male" genders.

Currently, there are 114 active trials in "Isala Klinieken". 2 are not yet recruiting, 58 are recruiting, 49 are Active, not recruiting, and 5 are Enrolling by invitation. In total, there were 156 completed trials in Isala Klinieken, undefined suspended trials, and 26 terminated clinical trials to date.

Out of the total trials that were conducted in Isala Klinieken, 3 "Phase 1" clinical trials were conducted, 51 "Phase 2" clinical trials and 94 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 30 trials, and there were also 95 trials that are defined as “Not Applicable".

Isala Klinieken has several departments that took part in Clinical trials: "Diabetes centre, Isala Clinics" - 2 trials